<http://webisa.webdatacommons.org/prov/74520504>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/341282503> .
<http://webisa.webdatacommons.org/prov/151309078>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/341282503> .
<http://webisa.webdatacommons.org/prov/376900007>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/341282503> .
<http://webisa.webdatacommons.org/341282503>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<freshpatents.com> .
<http://webisa.webdatacommons.org/prov/75579774>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/341282503> .
<http://webisa.webdatacommons.org/341282503>	<http://www.w3.org/ns/prov#value>	"Intravenous formulations may include carriers, excipients or stabilizers including, without limitation, calcium, human serum albumin, citrate, acetate, calcium chloride, carbonate, and other salts." .
<http://webisa.webdatacommons.org/341282503>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/152103475>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/341282503> .
<http://webisa.webdatacommons.org/prov/71536851>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/341282503> .